Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AKAN vs AUST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AUST Captures Overall Composite Edge (39.4 SELL vs 39.8 SELL), While AKAN Leads 3–2 on Growth & Valuation Pillars

AUST Overall Winner 6-Pillar Tally: AKAN 3 – 2 AUST (1 Tie) Matrix Metrics: AKAN 3 – 3 AUST

As of Nov 20, 2026, Austin Gold Corp. (AUST) captures the overall head-to-head institutional edge over Akanda Corp. Common Shares (AKAN) on higher Unified Composite conviction (39.4/100 SELL vs. 39.8/100 SELL) after splitting the core matrix 3–3 (led by Profitability & Quality, Options & Positioning), while AKAN wins 3–2 across the 6-pillar growth and valuation breakdown. AKAN trades at $4.23 (N/M Forward P/E, -1254.5% operating margin) versus AUST at $0.53 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: AUST earns the overall head-to-head edge with a stronger Unified Composite Score (39.4/100 SELL vs. AKAN 39.8/100 SELL) and 1.91β · 77% Vol risk profile, whereas AKAN leads top-line expansion (+21.9% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although AUST compares more favorably head-to-head, both AKAN (39.8/100 SELL) and AUST (39.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: AKAN is currently in a Breakdown options structure phase (RSI 75.2); meanwhile AUST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AKAN vs AUST
AKAN NASDAQ
Akanda Corp. Common Shares
Medicinal Chemicals & Botanical Products
$4.23
+23.32% 1D
Market Cap $12.2M
TTM Revenue $662,469
Forward P/E N/M
Beta / 30D Vol 4.82β · 524% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 75
RSI-14: 75.2 · SMA20: $1.52 · SMA50: $1.88
AUST NYSE American Head-to-Head Winner
Austin Gold Corp.
Gold And Silver Ores
$0.53
-8.58% 1D
Market Cap $7.9M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.91β · 77% Vol
Unified Composite Score
39.4 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 23
RSI-14: 23.3 · SMA20: $0.73 · SMA50: $0.88

6-Pillar Scorecard Institutional Category Breakdown (AKAN 3 – 2 AUST)

Columns: Metric · AKAN · AUST
1. Valuation Multiples AKAN
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 18.5x N/M
2. Growth & Scale AKAN
Revenue Growth (YoY) +21.9% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $662,469 N/A
Market Cap $12.2M $7.9M
3. Profitability & Quality AUST
Gross Margin -12.0% N/A
Operating Margin -1254.5% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -60.9% -33.7%
4. Balance Sheet & Cash Flow AKAN
Cash Generation (TTM) -$7.9M EBITDA -$2.7M
Cash Flow Margin N/A N/A
Net Cash / Leverage -60.9% ROE $0.46 Book/Sh · -33.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AUST
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Drug Manufacturers - Specialty & Generic Operator Gold Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AKAN (3) vs AUST (3)
Institutional Metric AKAN AUST Criterion Row Edge
Market Capitalization
Scale
$12.2M $7.9M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+21.9% +0.0% Higher Growth AKAN
Operating Margin (TTM)
Profitability
-1254.5% 0.0% Higher Margin AUST
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-60.9% -33.7% Higher ROE AUST
52-Week Range Position
Momentum
5% ($0–$79) 0% ($1–$4) Stronger Trend AKAN
Beta / 30D Volatility
Risk Regime
4.82β · 524% Vol 1.91β · 77% Vol Lower Realized Risk AUST
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 39.4 / 100 (SELL) Higher Composite AKAN
Trailing 12M Revenue (USD)
Operating Scale
$662,469 N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-12.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 18.5x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.9M EBITDA (-60.9% ROE) -$2.7M ($0.46 Book/Sh · -33.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AKAN +301.64 pp
AKAN: +267.83% · AUST: -33.81%
3M Horizon AKAN +74.28 pp
AKAN: +14.17% · AUST: -60.11%
6M Horizon AUST +25.22 pp
AKAN: -84.4% · AUST: -59.18%
1Y Horizon AKAN +425.58 pp
AKAN: +358.29% · AUST: -67.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKAN vs AUST. Trailing 12-month operating profitability (AKAN -1254.5% vs AUST 0.0%) and valuation multiples (AKAN N/M vs AUST N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AKAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$662,469
Gross Margin-12.0%
Op. Margin-1254.5%
ROE / Fwd P/E-60.9% · N/M
AUST ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-33.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AKAN BREAKDOWN
140d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact AKAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AUST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AUST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AKAN Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $12.2M market capitalization and -1254.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AUST Moat Profile Cyclical / Execution-Driven Positioning
Gold Operator
Competes within the Gold value chain with $7.9M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AKAN vs AUST Key Questions & Quantitative Answers

As of Nov 20, 2026, Austin Gold Corp. (AUST) captures the overall head-to-head institutional edge over Akanda Corp. Common Shares (AKAN) on higher Unified Composite conviction (39.4/100 SELL vs. 39.8/100 SELL) after splitting the core matrix 3–3 (led by Profitability & Quality, Options & Positioning), while AKAN wins 3–2 across the 6-pillar growth and valuation breakdown. AKAN trades at $4.23 (N/M Forward P/E, -1254.5% operating margin) versus AUST at $0.53 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: AUST earns the overall head-to-head edge with a stronger Unified Composite Score (39.4/100 SELL vs. AKAN 39.8/100 SELL) and 1.91β · 77% Vol risk profile, whereas AKAN leads top-line expansion (+21.9% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although AUST compares more favorably head-to-head, both AKAN (39.8/100 SELL) and AUST (39.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: AKAN is currently in a Breakdown options structure phase (RSI 75.2); meanwhile AUST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AKAN leads the Growth & Scale pillar: AKAN posts +21.9% YoY revenue growth and +0.0% YoY earnings growth on $662,469 TTM revenue (-12.0% gross margin, -1254.5% operating margin), compared with AUST at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, AKAN generates $662,469 in USD-normalized revenue versus N/A for AUST. In operating R&D and SG&A reinvestment, AKAN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AUST.

AKAN screens cheaper on headline valuation multiples. AKAN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 18.5x EV/Revenue (unreported EBITDA margin), whereas AUST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AKAN (-60.9% ROE) versus AUST (-33.7% ROE) capital efficiency.

In options market volatility and institutional positioning, AKAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (4.82β · 524% Vol realized risk). By comparison, AUST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.91β · 77% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.